ELISA – Products

This app note highlights how a microfluidic immunoassay simplifies HCP detection using integrated reagents and automation.

A no-code, science-aware SDMS for modern labs. Sapio Scientific Data Cloud unifies and contextualizes data across instruments and systems, delivering AI-ready insights, seamless integration, and frictionless scientific analysis at scale

Amsbio expands antibody portfolio with new markers for precise stem cell research and quality assurance.

Aptamer Group plc is pleased to announce the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA).

Tecan has acquired assets related to key ELISA immunoassay products, expanding its diagnostic portfolio and ensuring continued availability of specialty diagnostic kits.

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

Revvity, Inc. (NYSE: RVTY), announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.

BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow.

Stem cells can self-renew and differentiate, with potential for treating diseases like cancer and heart disease. Cytokines aid in this process. Sino Biological provides recombinant cytokines and research reagents.